DAY One Biopharmaceuticals
UEI: G9SZJB5MEHR3
• CAGE: 9W5Q5
Overview
Awardee Type
Parent
Company Description
Day One Biopharmaceuticals is a clinical-stage company dedicated to developing and commercializing innovative targeted therapies for patients of all ages.
Name
DAY One Biopharmaceuticals
Website
Headquarters
Brisbane, CA
United States
United States
Most Recent Award
March 8, 2025
Calculating
Federal contract recipient
DAY ONE BIOPHARMACEUTICALS, INC
(UEI G9SZJB5MEHR3, CAGE 9W5Q5)
is headquartered in Brisbane CA.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in May 2021 and
federally registered in
April 2024.
Federal Award Analysis
DAY One Biopharmaceuticals federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
DAY ONE BIOPHARMACEUTICALS, INC
UEI
G9SZJB5MEHR3
CAGE Code
9W5Q5
Primary NAICS
SBA Certifications
None
Self Certifications
For Profit Organization
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
May 26, 2021
Initial Registration
April 24, 2024
Last Registration
Feb. 18, 2025
Registration Activation
Feb. 18, 2025
Registration Expiration
Feb. 7, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Reported PSC
Accepts Credit Cards
No
People
Vendor contacts at DAY One Biopharmaceuticals
GSA Schedules and Price Lists
- DAY One Biopharmaceuticals
- PoP: 12/6/24 - 12/6/29
- Obligated: $25,906
- DAY One Biopharmaceuticals
- PoP: 6/2/24 - 11/30/24 (Ended)